Lye M. Tho
Petaling Jaya, Malaysia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Advancing Precision Medicine in Non-Small Cell Lung Cancer Diagnostics in a Southeast Asian Country.
Advancing Precision Medicine in Non-Small Cell Lung Cancer Diagnostics in a Southeast Asian Country.
Journal: Cancer management and research
Published: October 29, 2025
Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation-positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 20, 2025
Tepotinib Plus an EGFR Tyrosine Kinase Inhibitor in Patients With EGFR-Mutant MET-Altered NSCLC: A Case Series.
Journal: Clinical lung cancer
Published: October 28, 2024
Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 27, 2024
Real-world efficacy of low dose osimertinib as second-line treatment in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer.
Journal: Translational lung cancer research
Published: March 14, 2024
The potential role of artificial intelligence-assisted chest X-ray imaging in detecting early-stage lung cancer in the community-a proposed algorithm for lung cancer screening in Malaysia.
Journal: The Medical journal of Malaysia
Published: January 30, 2024
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial.
Journal: The Lancet. Oncology
Published: January 19, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 27, 2023
Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?
Journal: Translational lung cancer research
Published: November 11, 2023
Real-World Treatment and Outcomes of ALK-Positive Metastatic Non-Small Cell Lung Cancer in a Southeast Asian Country.
Journal: Cancer management and research
Published: October 18, 2022
Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia.
Journal: Cancer management and research
Published: March 11, 2022
Programmed death-ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non-small-cell lung cancer in a resource-limited country.
Journal: Thoracic cancer
Published: January 27, 2022
Last Updated: 09/26/2026